133 related articles for article (PubMed ID: 32129558)
1. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.
Mills L; Lintzeris N; Bruno R; Montebello M; Dunlop A; Deacon RM; Copeland J; Jefferies M; Rivas C; Mammen K
Drug Alcohol Rev; 2020 May; 39(4):356-364. PubMed ID: 32129558
[TBL] [Abstract][Full Text] [Related]
2. Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.
Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N
Addiction; 2021 May; 116(5):1245-1255. PubMed ID: 33201546
[TBL] [Abstract][Full Text] [Related]
3. The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study.
Lintzeris N; Monds LA; Rivas G; Leung S; Withall A; Draper B
Drug Alcohol Rev; 2016 Nov; 35(6):673-677. PubMed ID: 27072851
[TBL] [Abstract][Full Text] [Related]
4. Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings.
Ryan A; Holmes J; Hunt V; Dunlop A; Mammen K; Holland R; Sutton Y; Sindhusake D; Rivas G; Lintzeris N
Drug Alcohol Rev; 2014 Jan; 33(1):33-42. PubMed ID: 24206571
[TBL] [Abstract][Full Text] [Related]
5. Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions.
Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N
Drug Alcohol Rev; 2022 Jan; 41(1):106-113. PubMed ID: 34189792
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A
Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300
[TBL] [Abstract][Full Text] [Related]
7. Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile.
Deacon RM; Mills L; Bruno R; Mammen K; Dunlop A; Childs S; Shakeshaft A; Holmes J; Lintzeris N
Addiction; 2023 Dec; 118(12):2457-2465. PubMed ID: 37421220
[TBL] [Abstract][Full Text] [Related]
8. Reliability of online self-report versions of the Australian Treatment Outcome Profile (ATOP) and Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) among people in residential treatment for substance use problems.
Carlyle M; Walter ZC; Theroux B; Leung J; Hides L
Addict Behav; 2023 Sep; 144():107756. PubMed ID: 37257357
[TBL] [Abstract][Full Text] [Related]
9. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis.
Hides L; Dawe S; Young RM; Kavanagh DJ
Addiction; 2007 Jan; 102(1):35-40. PubMed ID: 17207121
[TBL] [Abstract][Full Text] [Related]
10. Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.
Deacon RM; Mammen K; Holmes J; Dunlop A; Bruno R; Mills L; Graham R; Lintzeris N
Drug Alcohol Rev; 2020 Jul; 39(5):441-446. PubMed ID: 32395850
[TBL] [Abstract][Full Text] [Related]
11. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.
Martin G; Copeland J; Gates P; Gilmour S
Drug Alcohol Depend; 2006 Jun; 83(1):90-3. PubMed ID: 16310973
[TBL] [Abstract][Full Text] [Related]
12. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).
Adamson SJ; Kay-Lambkin FJ; Baker AL; Lewin TJ; Thornton L; Kelly BJ; Sellman JD
Drug Alcohol Depend; 2010 Jul; 110(1-2):137-43. PubMed ID: 20347232
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users.
van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
Int J Methods Psychiatr Res; 2013 Jun; 22(2):138-43. PubMed ID: 23670783
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a mental health subscale from the Quality of Well-Being Self-Administered.
Sarkin AJ; Groessl EJ; Carlson JA; Tally SR; Kaplan RM; Sieber WJ; Ganiats TG
Qual Life Res; 2013 Sep; 22(7):1685-96. PubMed ID: 23104088
[TBL] [Abstract][Full Text] [Related]
15. The Cannabis Problems Questionnaire: factor structure, reliability, and validity.
Copeland J; Gilmour S; Gates P; Swift W
Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel.
Amir M; Lewin-Epstein N; Becker G; Buskila D
Med Care; 2002 Oct; 40(10):918-28. PubMed ID: 12395025
[TBL] [Abstract][Full Text] [Related]
17. Psychometric validation of the depression and family functioning scale.
Williams V; François C; Danchenko N; Nelson L; Williams N; Yarr S; DiBenedetti D; Lançon C
Curr Med Res Opin; 2016; 32(4):639-50. PubMed ID: 26700415
[TBL] [Abstract][Full Text] [Related]
18. Development of a short cannabis problems questionnaire for adolescents in the community.
Proudfoot H; Vogl L; Swift W; Martin G; Copeland J
Addict Behav; 2010 Jul; 35(7):734-7. PubMed ID: 20356683
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing.
Swift W; Hall W; Teesson M
Drug Alcohol Depend; 2001 Jul; 63(2):147-53. PubMed ID: 11376919
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Evaluation of the Mental Health Continuum-Short Form in French Canadian Young Adults.
Doré I; O'Loughlin JL; Sabiston CM; Fournier L
Can J Psychiatry; 2017 Apr; 62(4):286-294. PubMed ID: 28363262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
